CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Typewriter raises $56M for jumping gene technology and in vivo CAR-T therapies

in vivo CAR-T therapiesPositive
AI Analysis

Summary

Typewriter raised $56 million to develop jumping gene technology for in vivo CAR-T therapies as an alternative to viral delivery and CRISPR-based approaches for genetic transplantation.

Importance:5/10
Sentiment:
0.60
fundingjumping genesCAR-Tgene therapyCRISPR alternative
Related Companies

Read the original article

Published by Endpoints News on September 2, 2026 11:00 AM

Read Original